{"name":"Universita degli Studi di Genova","slug":"universita-degli-studi-di-genova","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Amoxicillin Long","genericName":"Amoxicillin Long","slug":"amoxicillin-long","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Amoxicillin Short","genericName":"Amoxicillin Short","slug":"amoxicillin-short","indication":"Bacterial infections including otitis media, sinusitis, respiratory tract infections, urinary tract infections, and skin infections","status":"marketed"}]}],"pipeline":[{"name":"Amoxicillin Long","genericName":"Amoxicillin Long","slug":"amoxicillin-long","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Amoxicillin Short","genericName":"Amoxicillin Short","slug":"amoxicillin-short","phase":"marketed","mechanism":"Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking peptidoglycan cross-linking.","indications":["Bacterial infections including otitis media, sinusitis, respiratory tract infections, urinary tract infections, and skin infections","Helicobacter pylori eradication (as part of combination therapy)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5sdlQ4Q0FJZEtMM2RWUnhFbDE3RURySkFZTkxhU2RJX01Eb0tsd3MxRUlWclNQMXg1V2podkFIR0p5amV6RTNJUFpSWlI4ZDF5Wksw?oc=5","date":"2016-02-22","type":"pipeline","source":"Nature","summary":"Improvement of pyrazolo[3,4- d ]pyrimidines pharmacokinetic properties: nanosystem approaches for drug delivery - Nature","headline":"Improvement of pyrazolo[3,4- d ]pyrimidines pharmacokinetic properties: nanosystem approaches for drug delivery","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}